2.4.0.82410404 - Disclosure - Investments in and Advances to Partnerships - Due on Investments and Sale of Local Limited Partnership (Details)truefalsefalse1false USDfalsefalse$I2013Q2http://www.sec.gov/CIK0000722833instant2013-06-30T00:00:000001-01-01T00:00:00usdStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$I2012Q4http://www.sec.gov/CIK0000722833instant2012-12-31T00:00:000001-01-01T00:00:00usdStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$3false USDtruefalse$D2013Q2YTD_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_crpiii_LocalPartnershipsMemberhttp://www.sec.gov/CIK0000722833duration2013-01-01T00:00:002013-06-30T00:00:00falsefalseLocal Partnerships [Member]us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxisxbrldihttp://xbrl.org/2006/xbrldicrpiii_LocalPartnershipsMemberus-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxisexplicitMemberusdStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$4false USDtruefalse$D2012Q3Sep26-27_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_crpiii_VillaMirageMemberhttp://www.sec.gov/CIK0000722833duration2012-09-26T00:00:002012-09-27T00:00:00falsefalseVilla Mirage [Member]us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxisxbrldihttp://xbrl.org/2006/xbrldicrpiii_VillaMirageMemberus-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxisexplicitMemberusdStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$5false USDtruefalse$D2011Q4Nov14-15_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_crpiii_VillaMirageMemberhttp://www.sec.gov/CIK0000722833duration2011-11-14T00:00:002011-11-15T00:00:00falsefalseVilla Mirage [Member]us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxisxbrldihttp://xbrl.org/2006/xbrldicrpiii_VillaMirageMemberus-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxisexplicitMemberusdStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$6false USDtruefalse$D2012Q3_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_crpiii_VillaMirageMemberhttp://www.sec.gov/CIK0000722833duration2012-07-01T00:00:002012-09-30T00:00:00falsefalseVilla Mirage [Member]us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxisxbrldihttp://xbrl.org/2006/xbrldicrpiii_VillaMirageMemberus-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxisexplicitMemberusdStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$7false USDtruefalse$D2012Q4Dec30-31_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_crpiii_MontereyHillcrestMemberhttp://www.sec.gov/CIK0000722833duration2012-12-30T00:00:002012-12-31T00:00:00falsefalseMonterey/Hillcrest [Member]us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxisxbrldihttp://xbrl.org/2006/xbrldicrpiii_MontereyHillcrestMemberus-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxisexplicitMemberusdStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$8false USDtruefalse$D2012Q1Jan30-31_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_crpiii_MontereyHillcrestMemberhttp://www.sec.gov/CIK0000722833duration2012-01-30T00:00:002012-01-31T00:00:00falsefalseMonterey/Hillcrest [Member]us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxisxbrldihttp://xbrl.org/2006/xbrldicrpiii_MontereyHillcrestMemberus-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxisexplicitMemberusdStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$9false USDtruefalse$D2012Q1Feb1-29_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_crpiii_MontereyHillcrestMemberhttp://www.sec.gov/CIK0000722833duration2012-02-01T00:00:002012-02-29T00:00:00falsefalseMonterey/Hillcrest [Member]us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxisxbrldihttp://xbrl.org/2006/xbrldicrpiii_MontereyHillcrestMemberus-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxisexplicitMemberusdStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$10false USDtruefalse$D2012Q1_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_crpiii_MontereyHillcrestMemberhttp://www.sec.gov/CIK0000722833duration2012-01-01T00:00:002012-03-31T00:00:00falsefalseMonterey/Hillcrest [Member]us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxisxbrldihttp://xbrl.org/2006/xbrldicrpiii_MontereyHillcrestMemberus-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxisexplicitMemberusdStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$11false USDtruefalse$D2012Q2Jun17-18_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_crpiii_MeadowLanesMemberhttp://www.sec.gov/CIK0000722833duration2012-06-17T00:00:002012-06-18T00:00:00falsefalseMeadow Lanes [Member]us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxisxbrldihttp://xbrl.org/2006/xbrldicrpiii_MeadowLanesMemberus-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxisexplicitMemberusdStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$12false USDtruefalse$D2013Q2YTD_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_crpiii_MeadowLanesMemberhttp://www.sec.gov/CIK0000722833duration2013-01-01T00:00:002013-06-30T00:00:00falsefalseMeadow Lanes [Member]us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxisxbrldihttp://xbrl.org/2006/xbrldicrpiii_MeadowLanesMemberus-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxisexplicitMemberusdStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$13false USDtruefalse$I2012Q4_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_crpiii_MeadowLanesMemberhttp://www.sec.gov/CIK0000722833instant2012-12-31T00:00:000001-01-01T00:00:00falsefalseMeadow Lanes [Member]us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxisxbrldihttp://xbrl.org/2006/xbrldicrpiii_MeadowLanesMemberus-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxisexplicitMemberusdStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$14false USDtruefalse$D2012Q3Sep26-27_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_crpiii_ManagingGeneralPartnerMember_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_crpiii_VillaMirageMemberhttp://www.sec.gov/CIK0000722833duration2012-09-26T00:00:002012-09-27T00:00:00falsefalseManaging General Partner [Member]us-gaap_RelatedPartyTransactionsByRelatedPartyAxisxbrldihttp://xbrl.org/2006/xbrldicrpiii_ManagingGeneralPartnerMemberus-gaap_RelatedPartyTransactionsByRelatedPartyAxisexplicitMemberfalsefalseVilla Mirage [Member]us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxisxbrldihttp://xbrl.org/2006/xbrldicrpiii_VillaMirageMemberus-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxisexplicitMemberusdStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$15false USDtruefalse$D2012Q1Jan30-31_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_crpiii_ManagingGeneralPartnerMember_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_crpiii_MontereyHillcrestMemberhttp://www.sec.gov/CIK0000722833duration2012-01-30T00:00:002012-01-31T00:00:00falsefalseManaging General Partner [Member]us-gaap_RelatedPartyTransactionsByRelatedPartyAxisxbrldihttp://xbrl.org/2006/xbrldicrpiii_ManagingGeneralPartnerMemberus-gaap_RelatedPartyTransactionsByRelatedPartyAxisexplicitMemberfalsefalseMonterey/Hillcrest [Member]us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxisxbrldihttp://xbrl.org/2006/xbrldicrpiii_MontereyHillcrestMemberus-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxisexplicitMemberusdStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 3us-gaap_ScheduleOfEquityMethodInvestmentsLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalse11falsefalsefalse00falsefalsefalse12falsefalsefalse00falsefalsefalse13falsefalsefalse00falsefalsefalse14falsefalsefalse00falsefalsefalse15falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Schedule of Equity Method Investments [Line Items]2false 4crpiii_DueOnInvestmentsInPartnershipscrpiii_falsecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse119544119544USD$falsetruefalse2truefalsefalse119544119544USD$falsetruefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalse11falsefalsefalse00falsefalsefalse12truefalsefalse119544119544USD$falsetruefalse13truefalsefalse119544119544USD$falsetruefalse14falsefalsefalse00falsefalsefalse15falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryDue on Investments in PartnershipsNo definition available.false2Due on investments in partnerships3false 4us-gaap_InterestPayableCurrentAndNoncurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalse11falsefalsefalse00falsefalsefalse12truefalsefalse3397633976falsefalsefalse13truefalsefalse3397633976falsefalsefalse14falsefalsefalse00falsefalsefalse15falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryCarrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03.15(5)) -URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03.15(a)) -URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 15 -Subparagraph a -Article 7 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 15 -Subparagraph 5 -Article 9 false2Interest Payable4false 4crpiii_EquityMethodInvestmentSalePricecrpiii_falsecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5truefalsefalse65000006500000falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8truefalsefalse1892000018920000falsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalse11truefalsefalse29000002900000falsefalsefalse12falsefalsefalse00falsefalsefalse13falsefalsefalse00falsefalsefalse14falsefalsefalse00falsefalsefalse15falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryEquity Method Investment, Sale PriceNo definition available.false2Aggregate sales price of properties5false 4crpiii_EquityMethodInvestmentExpectedNetSalesProceedscrpiii_falsecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8truefalsefalse36941083694108falsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalse11falsefalsefalse00falsefalsefalse12truefalsefalse25925092592509falsefalsefalse13falsefalsefalse00falsefalsefalse14falsefalsefalse00falsefalsefalse15falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryEquity Method Investment, Expected Net Sales ProceedsNo definition available.false2Expected proceeds as a result of sale6false 4us-gaap_EquityMethodInvestmentNetSalesProceedsus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4truefalsefalse19033491903349falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9truefalsefalse36112883611288falsefalsefalse10falsefalsefalse00falsefalsefalse11falsefalsefalse00falsefalsefalse12falsefalsefalse00falsefalsefalse13falsefalsefalse00falsefalsefalse14falsefalsefalse00falsefalsefalse15falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryThis item represents the amount of net sales proceeds received on disposal of an equity method investment.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 35 -Paragraph 35 -URI http://asc.fasb.org/extlink&oid=7658923&loc=d3e32847-111569 false2Proceeds received as a result of sale7false 4us-gaap_EquityMethodInvestmentsus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalse11falsefalsefalse00falsefalsefalse12truefalsefalse26337182633718falsefalsefalse13truefalsefalse25824732582473falsefalsefalse14falsefalsefalse00falsefalsefalse15falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryThis item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.12) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=16385135&loc=d3e33749-111570 false2Investment balance8false 4us-gaap_EquityMethodInvestmentSoldCarryingAmountus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4truefalsefalse195662195662falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7truefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalse11falsefalsefalse00falsefalsefalse12falsefalsefalse00falsefalsefalse13falsefalsefalse00falsefalsefalse14falsefalsefalse00falsefalsefalse15falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryThis item represents the carrying amount of the entity's equity method investment which has been sold. This item is used only for purposes of disclosing the calculated gain (loss) on disposal of the subject equity method investment and not for reporting the carrying value of equity method investments as presented on the entity's balance sheet. For reporting the carrying value of equity method investments presented on the entity's balance sheet, the EquityMethodInvestments (Equity Method Investments) element would be used.No definition available.false2Investment balance at time of sale9false 4crpiii_DeferredCostsGrosscrpiii_falsedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8truefalsefalse36563656falsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalse11falsefalsefalse00falsefalsefalse12falsefalsefalse00falsefalsefalse13falsefalsefalse00falsefalsefalse14falsefalsefalse00falsefalsefalse15falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryDeferred Costs, GrossNo definition available.false2Net unamortized acquisition costs and property purchase costs10false 4us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalse11falsefalsefalse00falsefalsefalse12falsefalsefalse00falsefalsefalse13falsefalsefalse00falsefalsefalse14truefalsefalse325000325000falsefalsefalse15truefalsefalse946000946000falsefalsefalsexbrli:monetaryItemTypemonetaryExpenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 57 -Paragraph 2 -Subparagraph c -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 850 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864 false2Fees paid to related party in connection with transaction11false 4us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposalus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6truefalsefalse13826871382687falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10truefalsefalse27744522774452falsefalsefalse11falsefalsefalse00falsefalsefalse12falsefalsefalse00falsefalsefalse13falsefalsefalse00falsefalsefalse14falsefalsefalse00falsefalsefalse15falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryThis item represents the amount of gain (loss) arising from the disposal of an equity method investment.No definition available.false2Gain recorded as a result of sale12false 4us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairmentus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse4120941209USD$falsetruefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalse11falsefalsefalse00falsefalsefalse12truefalsefalse4120941209USD$falsetruefalse13falsefalsefalse00falsefalsefalse14falsefalsefalse00falsefalsefalse15falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryThis item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 18 -Paragraph 19 -Subparagraph h -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 35 -Paragraph 32 -URI http://asc.fasb.org/extlink&oid=7658923&loc=d3e32787-111569 false2Impairment loss as a result of salefalseInvestments in and Advances to Partnerships - Due on Investments and Sale of Local Limited Partnership (Details) (USD $)NoRoundingUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.capitalrealtypartners.net/role/InvestmentsInAndAdvancesToPartnershipsDueOnInvestmentsAndSaleOfLocalLimitedPartnershipDetails1512